---
abstract: Pleural effusion affects 1.5 million patients in the United States each
  year. New effusions require expedited investigation because treatments range from
  common medical therapies to invasive surgical procedures. The leading causes of
  pleural effusion in adults are heart failure, infection, malignancy, and pulmonary
  embolism. The patient's history and physical examination should guide evaluation.
  Small bilateral effusions in patients with decompensated heart failure, cirrhosis,
  or kidney failure are likely transudative and do not require diagnostic thoracentesis.
  In contrast, pleural effusion in the setting of pneumonia (parapneumonic effusion)
  may require additional testing. Multiple guidelines recommend early use of point-of-care
  ultrasound in addition to chest radiography to evaluate the pleural space. Chest
  radiography is helpful in determining laterality and detecting moderate to large
  pleural effusions, whereas ultrasonography can detect small effusions and features
  that could indicate complicated effusion (i.e., infection of the pleural space)
  and malignancy. Point-of-care ultrasound should also guide thoracentesis because
  it reduces complications. Computed tomography of the chest can exclude other causes
  of dyspnea and suggest complicated parapneumonic or malignant effusion. When diagnostic
  thoracentesis is indicated, Light's criteria can help differentiate exudates from
  transudates. Pleural aspirate should routinely be evaluated using Gram stain, cell
  count with differential, culture, cytology, protein, l-lactate dehydrogenase, and
  pH levels. Additional assessments should be individualized, such as tuberculosis
  testing in high-prevalence regions. Parapneumonic effusions are the most common
  cause of exudates. A pH level less than 7.2 is indicative of complicated parapneumonic
  effusion and warrants prompt consultation for catheter or chest tube drainage, possible
  tissue plasminogen activator/deoxyribonuclease therapy, or thoracoscopy. Malignant
  effusions are another common cause of exudative effusions, with recurrent effusions
  having a poor prognosis.
authors:
- Shen-Wagner, Joy
- Gamble, Christine
- MacGilvray, Phyllis
category: Clinical Review
clinical_significance: High
cme_credits: 0.0
doi: ''
evidence_level: ''
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/37983698/
file_path: 2023/11/pleural-effusion-diagnostic-approach-in-adults.md
issue: '5'
keywords:
- Pleural Effusion
- Exudates and Transudates
- Heart Failure
- Humans
- Neoplasms
- Adult
- Tissue Plasminogen Activator
last_updated: '2025-08-09'
mesh_terms:
- Humans
- Adult
- Tissue Plasminogen Activator
- Pleural Effusion
- Exudates and Transudates
- Neoplasms
- Heart Failure
original_format: PubMed
pages: 464-475
patient_population: Adults
peer_reviewed: true
pmid: '37983698'
processed_date: '2025-08-09'
publication_date: '2023-11-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-08-09'
reading_time_minutes: 3
source: American family physician
specialties:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: 'Pleural Effusion: Diagnostic Approach in Adults.'
topics:
- Family Medicine
volume: '108'
publication_types: &id001
- Journal Article
pubmed_content_enriched: true
pubmed_full_data:
  pmid: '37983698'
  title: 'Pleural Effusion: Diagnostic Approach in Adults.'
  abstract:
    text: Pleural effusion affects 1.5 million patients in the United States each
      year. New effusions require expedited investigation because treatments range
      from common medical therapies to invasive surgical procedures. The leading causes
      of pleural effusion in adults are heart failure, infection, malignancy, and
      pulmonary embolism. The patient's history and physical examination should guide
      evaluation. Small bilateral effusions in patients with decompensated heart failure,
      cirrhosis, or kidney failure are likely transudative and do not require diagnostic
      thoracentesis. In contrast, pleural effusion in the setting of pneumonia (parapneumonic
      effusion) may require additional testing. Multiple guidelines recommend early
      use of point-of-care ultrasound in addition to chest radiography to evaluate
      the pleural space. Chest radiography is helpful in determining laterality and
      detecting moderate to large pleural effusions, whereas ultrasonography can detect
      small effusions and features that could indicate complicated effusion (i.e.,
      infection of the pleural space) and malignancy. Point-of-care ultrasound should
      also guide thoracentesis because it reduces complications. Computed tomography
      of the chest can exclude other causes of dyspnea and suggest complicated parapneumonic
      or malignant effusion. When diagnostic thoracentesis is indicated, Light's criteria
      can help differentiate exudates from transudates. Pleural aspirate should routinely
      be evaluated using Gram stain, cell count with differential, culture, cytology,
      protein, l-lactate dehydrogenase, and pH levels. Additional assessments should
      be individualized, such as tuberculosis testing in high-prevalence regions.
      Parapneumonic effusions are the most common cause of exudates. A pH level less
      than 7.2 is indicative of complicated parapneumonic effusion and warrants prompt
      consultation for catheter or chest tube drainage, possible tissue plasminogen
      activator/deoxyribonuclease therapy, or thoracoscopy. Malignant effusions are
      another common cause of exudative effusions, with recurrent effusions having
      a poor prognosis.
  authors:
  - last_name: Shen-Wagner
    fore_name: Joy
    initials: J
    affiliation: University of South Carolina School of Medicine Greenville; Prisma
      Health Family Medicine Residency Program, Greenville, South Carolina.
  - last_name: Gamble
    fore_name: Christine
    initials: C
    affiliation: University of South Carolina School of Medicine Greenville; Prisma
      Health Family Medicine Residency Program; Prisma Health Center for Family Medicine,
      Greenville, South Carolina.
  - last_name: MacGilvray
    fore_name: Phyllis
    initials: P
    affiliation: University of South Carolina School of Medicine Greenville; Prisma
      Health Family Medicine Residency Program, Greenville, South Carolina.
  journal_info:
    title: American family physician
    iso_abbreviation: Am Fam Physician
    volume: '108'
    issue: '5'
  publication_info:
    year: '2023'
    month: '11'
    full_date: '2023-11-01'
  article_ids: {}
  mesh_terms:
  - descriptor: Humans
    major_topic: false
  - descriptor: Adult
    major_topic: false
  - descriptor: Tissue Plasminogen Activator
    major_topic: false
  - descriptor: Pleural Effusion
    major_topic: true
    qualifiers:
    - qualifier: diagnostic imaging
      major_topic: false
    - qualifier: etiology
      major_topic: false
  - descriptor: Exudates and Transudates
    major_topic: false
    qualifiers:
    - qualifier: metabolism
      major_topic: false
  - descriptor: Neoplasms
    major_topic: true
    qualifiers:
    - qualifier: complications
      major_topic: false
  - descriptor: Heart Failure
    major_topic: true
    qualifiers:
    - qualifier: diagnosis
      major_topic: false
  publication_types: *id001
related_articles:
- pmid: '37983698'
  title: 'Pleural Effusion: Diagnostic Approach in Adults.'
  authors:
  - name: Shen-Wagner J
    authtype: Author
    clusterid: ''
  - name: Gamble C
    authtype: Author
    clusterid: ''
  - name: MacGilvray P
    authtype: Author
    clusterid: ''
  source: Am Fam Physician
  pubdate: 2023 Nov
- pmid: '25077579'
  title: Diagnostic approach to pleural effusion.
  authors:
  - name: Saguil A
    authtype: Author
    clusterid: ''
  - name: Wyrick K
    authtype: Author
    clusterid: ''
  - name: Hallgren J
    authtype: Author
    clusterid: ''
  source: Am Fam Physician
  pubdate: 2014 Jul 15
- pmid: '32069085'
  title: Pleural Fluid suPAR Levels Predict the Need for Invasive Management in Parapneumonic
    Effusions.
  authors:
  - name: Arnold DT
    authtype: Author
    clusterid: ''
  - name: Hamilton FW
    authtype: Author
    clusterid: ''
  - name: Elvers KT
    authtype: Author
    clusterid: ''
  - name: Frankland SW
    authtype: Author
    clusterid: ''
  - name: Zahan-Evans N
    authtype: Author
    clusterid: ''
  - name: Patole S
    authtype: Author
    clusterid: ''
  - name: Medford A
    authtype: Author
    clusterid: ''
  - name: Bhatnagar R
    authtype: Author
    clusterid: ''
  - name: Maskell NA
    authtype: Author
    clusterid: ''
  source: Am J Respir Crit Care Med
  pubdate: 2020 Jun 15
- pmid: '9207521'
  title: 'CT appearance of parapneumonic effusions in children: findings are not specific
    for empyema.'
  authors:
  - name: Donnelly LF
    authtype: Author
    clusterid: ''
  - name: Klosterman LA
    authtype: Author
    clusterid: ''
  source: AJR Am J Roentgenol
  pubdate: 1997 Jul
- pmid: '14980272'
  title: Useful clinical biological markers in diagnosis of pleural effusions in children.
  authors:
  - name: Segura RM
    authtype: Author
    clusterid: ''
  source: Paediatr Respir Rev
  pubdate: '2004'
---

# Pleural Effusion: Diagnostic Approach in Adults.

**Authors:** Shen-Wagner, Joy, Gamble, Christine, MacGilvray, Phyllis

**Published in:** American family physician | Vol. 108, No. 5 | 2023-11-01

**Links:** [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/37983698/)

## Abstract

Pleural effusion affects 1.5 million patients in the United States each year. New effusions require expedited investigation because treatments range from common medical therapies to invasive surgical procedures. The leading causes of pleural effusion in adults are heart failure, infection, malignancy, and pulmonary embolism. The patient's history and physical examination should guide evaluation. Small bilateral effusions in patients with decompensated heart failure, cirrhosis, or kidney failure are likely transudative and do not require diagnostic thoracentesis. In contrast, pleural effusion in the setting of pneumonia (parapneumonic effusion) may require additional testing. Multiple guidelines recommend early use of point-of-care ultrasound in addition to chest radiography to evaluate the pleural space. Chest radiography is helpful in determining laterality and detecting moderate to large pleural effusions, whereas ultrasonography can detect small effusions and features that could indicate complicated effusion (i.e., infection of the pleural space) and malignancy. Point-of-care ultrasound should also guide thoracentesis because it reduces complications. Computed tomography of the chest can exclude other causes of dyspnea and suggest complicated parapneumonic or malignant effusion. When diagnostic thoracentesis is indicated, Light's criteria can help differentiate exudates from transudates. Pleural aspirate should routinely be evaluated using Gram stain, cell count with differential, culture, cytology, protein, l-lactate dehydrogenase, and pH levels. Additional assessments should be individualized, such as tuberculosis testing in high-prevalence regions. Parapneumonic effusions are the most common cause of exudates. A pH level less than 7.2 is indicative of complicated parapneumonic effusion and warrants prompt consultation for catheter or chest tube drainage, possible tissue plasminogen activator/deoxyribonuclease therapy, or thoracoscopy. Malignant effusions are another common cause of exudative effusions, with recurrent effusions having a poor prognosis.

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Family Medicine

## MeSH Terms

Humans, Adult, Tissue Plasminogen Activator, Pleural Effusion, Exudates and Transudates, Neoplasms, Heart Failure

## Article Content

**Authors:** Shen-Wagner, Joy, Gamble, Christine, MacGilvray, Phyllis

**Published in:** American family physician | Vol. 108, No. 5 | 2023-11-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/37983698/)


## Article Content


### Main Content


Pleural effusion affects 1.5 million patients in the United States each year. New effusions require expedited investigation because treatments range from common medical therapies to invasive surgical procedures. The leading causes of pleural effusion in adults are heart failure, infection, malignancy, and pulmonary embolism. The patient's history and physical examination should guide evaluation. Small bilateral effusions in patients with decompensated heart failure, cirrhosis, or kidney failure are likely transudative and do not require diagnostic thoracentesis. In contrast, pleural effusion in the setting of pneumonia (parapneumonic effusion) may require additional testing. Multiple guidelines recommend early use of point-of-care ultrasound in addition to chest radiography to evaluate the pleural space. Chest radiography is helpful in determining laterality and detecting moderate to large pleural effusions, whereas ultrasonography can detect small effusions and features that could indicate complicated effusion (i.e., infection of the pleural space) and malignancy. Point-of-care ultrasound should also guide thoracentesis because it reduces complications. Computed tomography of the chest can exclude other causes of dyspnea and suggest complicated parapneumonic or malignant effusion. When diagnostic thoracentesis is indicated, Light's criteria can help differentiate exudates from transudates. Pleural aspirate should routinely be evaluated using Gram stain, cell count with differential, culture, cytology, protein, l-lactate dehydrogenase, and pH levels. Additional assessments should be individualized, such as tuberculosis testing in high-prevalence regions. Parapneumonic effusions are the most common cause of exudates. A pH level less than 7.2 is indicative of complicated parapneumonic effusion and warrants prompt consultation for catheter or chest tube drainage, possible tissue plasminogen activator/deoxyribonuclease therapy, or thoracoscopy. Malignant effusions are another common cause of exudative effusions, with recurrent effusions having a poor prognosis.

Porcel JM, et al. Diagnostic approach to pleural effusion in adults. Am Fam Physician. 2006;73(7):1211-1220.

Camus P, et al. Drug-induced and iatrogenic infiltrative lung disease. Clin Chest Med. 2004;25(3):479-519.

Hooper C, et al.; BTS Pleural Guideline Group. Investigation of a unilateral pleural effusion in adults: British Thoracic Society pleural disease guideline 2010. Thorax. 2010;65(suppl 2):ii4-ii17.

Tong S, et al. Distinguishing tuberculosis pleural effusion from parasitic pleural effusion using pleural fluid characteristics: a case control study. Medicine (Baltimore). 2019;98(5):e14238.

Aboudara M, et al. Update in the management of pleural effusions. Med Clin North Am. 2019;103(3):475-485.

Taghizadeh N, et al. US hospitalizations for malignant pleural effusions: data from the 2012 national inpatient sample. Chest. 2017;151(4):845-854.

Bateman M, et al. Pleural effusion outcomes in intensive care: analysis of a large clinical database. J Intensive Care Med. 2020;35(1):48-54.

Dancel R, et al.; Society of Hospital Medicine Point of Care Ultrasound Task Force. Recommendations on the use of ultrasound guidance for adult thoracentesis. J Hosp Med. 2018;13(2):126-135.

Walker SP, et al. Nonmalignant pleural effusions: a prospective study of 356 consecutive unselected patients. Chest. 2017;151(5):1099-1105.

Zhan N, et al. Clinical characteristics of COVID-19 complicated with pleural effusion. BMC Infect Dis. 2021;21(1):176.

Cardinale L, et al. Revisiting signs, strengths and weaknesses of standard chest radiography in patients of acute dyspnea in the emergency department. J Thorac Dis. 2012;4(4):398-407.

Volpicelli G, et al.; International Liaison Committee on Lung Ultrasound (ILCLUS) for International Consensus Conference on Lung Ultrasound (ICC-LUS). International evidence-based recommendations for point-of-care lung ultrasound. Intensive Care Med. 2012;38(4):577-591.

Soni NJ, et al. Ultrasound in the diagnosis and management of pleural effusions. J Hosp Med. 2015;10(12):811-816.

Roberts ME, et al.; BTS Pleural Guideline Development Group. British Thoracic Society guideline for pleural disease. Thorax. 2023;78(suppl 3):s1-s42.

Shen KR, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017;153(6):e129-e146.

Lichtenstein D, et al. Comparative diagnostic performances of auscultation, chest radiography, and lung ultrasonography in acute respiratory distress syndrome. Anesthesiology. 2004;100(1):9-15.

Shkolnik B, et al. Diagnostic accuracy of thoracic ultrasonography to differentiate transudative from exudative pleural effusion. Chest. 2020;158(2):692-697.

Gartlehner G, et al. Point-of-care ultrasonography in patients with acute dyspnea: an evidence report for a clinical practice guideline by the American College of Physicians [published correction appears in Ann Intern Med. 2022; 175(3): 458â€“459]. Ann Intern Med. 2021;174(7):967-976.

Hallifax RJ, et al. State-of-the-art: radiological investigation of pleural disease. Respir Med. 2017;124:88-99.

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/37983698/) (reference)

---

*Processed: 2025-08-09* | *PubMed Enhanced: 2025-07-30*
